Azurrx Biopharma Inc (AZRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AZRX | BMY | AMGN | GILD | REGN |
| Company | Azurrx Biopharma Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.38 | 70.32 | 243.77 | 82.36 | 749.20 |
| High | 3.66 | 72.88 | 246.57 | 82.50 | 758.72 |
| Low | 3.38 | 69.80 | 236.37 | 80.48 | 741.45 |
| Last | 3.45 | 72.77 | 246.53 | 81.39 | 751.20 |
| Change | +0.07 | +1.54 | +0.12 | -2.61 | -6.80 |
| % Change | +2.07% | +2.16% | +0.05% | -3.11% | -0.90% |
| Volume | 629,000 | 13,015,300 | 5,489,100 | 10,933,700 | 935,100 |
| 20-Day Average Volume | 1,053,631 | 8,542,355 | 2,494,865 | 6,597,720 | 656,510 |
| Previous Close | 3.38 | 71.23 | 246.41 | 84.00 | 758.00 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.38 | 72.44 | 262.17 | 84.62 | 728.25 |
| 20-Day Raw Stochastic | 2.44% | 57.12% | 25.11% | 11.65% | 88.42% |
| 20-Day Relative Strength | 30.93% | 47.50% | 31.09% | 40.95% | 55.90% |
| Weighted Alpha | -75.37 | +6.90 | +5.80 | +31.80 | +17.50 |
| Today's Opinion | 100% Sell | 40% Sell | 8% Sell | 40% Buy | 64% Buy |
| Previous Opinion | 100% Sell | 56% Sell | 8% Sell | 40% Buy | 64% Buy |
| Last Month's Opinion | 100% Sell | 24% Sell | 40% Buy | 80% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -22.12% since 09/14/21 | -0.30% since 01/26/23 | -3.28% since 01/26/23 | -2.67% since 01/26/23 | +1.20% since 01/26/23 |
| Low | 3.36 on 09/20/21 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.48 on 02/02/23 | 732.49 on 01/30/23 |
| High | 4.39 on 09/15/21 | 73.45 on 01/27/23 | 255.50 on 01/27/23 | 84.65 on 02/01/23 | 762.09 on 02/01/23 |
| 1-Month | |||||
| %Chg | -40.60% since 08/20/21 | +1.14% since 12/30/22 | -6.13% since 12/30/22 | -5.20% since 12/30/22 | +4.12% since 12/30/22 |
| Low | 3.36 on 09/20/21 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.48 on 02/02/23 | 668.00 on 01/09/23 |
| High | 7.05 on 09/10/21 | 75.00 on 01/24/23 | 276.84 on 01/11/23 | 88.29 on 01/06/23 | 762.09 on 02/01/23 |
| 3-Month | |||||
| %Chg | -57.06% since 06/21/21 | -6.04% since 11/02/22 | -8.36% since 11/02/22 | +4.51% since 11/02/22 | +1.45% since 11/02/22 |
| Low | 3.36 on 09/20/21 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 77.16 on 11/03/22 | 668.00 on 01/09/23 |
| High | 8.57 on 08/18/21 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 779.00 on 12/08/22 |
| 6-Month | |||||
| %Chg | -75.18% since 03/19/21 | -0.70% since 08/02/22 | +1.07% since 08/02/22 | +36.70% since 08/02/22 | +30.65% since 08/02/22 |
| Low | 3.36 on 09/20/21 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 60.62 on 08/05/22 | 572.22 on 09/06/22 |
| High | 14.90 on 03/22/21 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 779.00 on 12/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,175 | 151,446,384 | 131,479,200 | 105,356,496 | 82,547,712 |
| Shares Outstanding, K | 9,326 | 2,126,160 | 533,579 | 1,254,244 | 108,902 |
| Annual Sales | 0 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 16,071,700,000 |
| Annual Net Income | -32,670,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 8,075,300,000 |
| Last Quarter Sales | 0 | 11,218,000,000 | 6,652,000,000 | 7,042,000,000 | 2,936,200,000 |
| Last Quarter Net Income | -9,280,000 | 1,606,000,000 | 2,143,000,000 | 1,789,000,000 | 1,315,700,000 |
| 60-Month Beta | 1.51 | 0.43 | 0.64 | 0.39 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.99 on 10/25/22 | 4.09 on 01/31/23 | 1.90 on 10/27/22 | 11.14 on 11/03/22 |
| Latest Earnings Date | 08/20/21 | 02/02/23 | 01/31/23 | 02/02/23 | 02/03/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 12/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.42 | 14.27 | 13.35 | 13.80 |
